![](https://investorshub.advfn.com/uicon/123861.png?cb=1494451232)
Saturday, October 06, 2018 7:17:41 PM
Conditional License includes Technology to be provided by BLDV & Cann10 NA
September 25, 2018 Blue Diamond Ventures Inc. (OTC PK: BLDV) Denver Colorado:
Blue Diamond Consulting LLC prepared winning application
The final decision for the five cannabis oil processing licenses in Virginia was announced today, one of 51 applications, BLDV client Dharma Pharmaceuticals was awarded a conditional permit in health area three. The project will be the first to introduce the Cannareet® product line into North America.
“This is proof of the value of the tech packages we are offering and validation of the current business model of BLDV” said Josh Alper, CEO of BLDV, “the announcement was made yesterday and the timing could not be better, we just completed our first Medical Cannabis Technology event in California on Thursday last week, where we showcased a number of solutions, including Products from Cann10, Harvest 360 Tech, CannabiDose and others."
Blue Diamond Consulting LLC, a wholly owned subsidiary of BLDV, prepared the application in Virginia, and was able to demonstrate the value of Cannareet and other tech to expand the Dharma model. Harvest 360 Tech, strategic partner of BLDV, will introduce a spatial modeling Chemistry Mapping Solution, to the Virginia project as part of a research and development package that includes community outreach integrated into patient and doctor outcomes.
More information will made available as received.
Showcase info from September 20th in California below.
About BLDV: Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable pharmaceutical-grade cannabis products/services that are produced, delivered and consumed utilizing fewer natural resources. Blue Diamond Ventures Inc. seeks opportunities in medical cannabis markets and is driven by critical thinking and the scientific method.
Safe Harbor: This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.
Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer (844) 637-6377 info@bldvinc.com www.bldvinc.com
Source: https://backend.otcmarkets.com/otcapi/company/dns/news/document/32981/content
Supporting link - Pharmaceutical Processors in the Commonwealth of Virginia:
https://www.dhp.virginia.gov/pharmacy/PharmaceuticalProcessing/docs/PPPReferenceSept2018.pdf
Go BLDV!
Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM